Skip to content

As U.S. Slashes $500M in mRNA Funding, Bordeaux Biotech bYoRNA Raises €1.5M to Reinvent RNA Production

bYoRNA is developing a patented fermentation process that could cut RNA production costs by 100x, improve safety, and enable global access to next-generation vaccines and therapies. This breakthrough comes as the U.S. is rejecting mRNA, a move that complicates the startup's business strategy.

The bYoRNA team

This post is for paying subscribers only

Subscribe

Already have an account? Sign In

Latest

🇫🇷 French Tech Wire: Startup Nation Confronts Austerity Nation...Liberté, Égalité, Subventionné?

🇫🇷 French Tech Wire: Startup Nation Confronts Austerity Nation...Liberté, Égalité, Subventionné?

A French Tech Mission report positions startups as nationwide job engines rather than elite subsidy hogs before the budget axe falls. Also: A new new new digital minister; a Nobel win for economist Aghion; RIVRS pivots to Asia + new publishing model; €105M biotech raise leads funding rounds.

Members Public